Clinical Trials on Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1 in Hong Kong
Total 10 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Germany, Hong Kong
-
Chinese University of Hong KongRecruitingCardiovascular Diseases | Stroke | Diabetes Mellitus | Diabetes | Diabetic Angiopathies | Diabetic Retinopathy | Type 1 Diabetes | Diabetic Kidney Disease | Diabetic Nephropathies | Type 2 Diabetes | Coronary Heart DiseaseHong Kong
-
Zhujiang HospitalNational Natural Science Foundation of ChinaRecruitingColorectal Cancer | Inflammatory Bowel Disease | Type2 Diabetes Mellitus | Atherosclerotic Cardiovascular DiseaseChina
-
BIOTRONIK Asia Pacific Pte LtdCompletedMyocardial Ischemia | Coronary Artery Disease | Diabetes Mellitus Type 1 or 2China, India, Malaysia, Vietnam, Sri Lanka
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
US Department of Veterans AffairsCompletedType 2 Diabetes MellitusUnited States
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
Chromaderm, Inc.CompletedDiabetic Neuropathies | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Insulin-DependentCanada, United States, Croatia, Finland, India, Lithuania, Netherlands, United Kingdom
-
Tranzyme, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | GastroparesisUnited States, Belgium, Denmark, Finland, Germany, Norway, Poland, Sweden
-
Mannkind CorporationTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | AsthmaBrazil, United States, Canada, Poland, Russian Federation, Argentina, Czech Republic, Mexico, Spain, Ukraine, United Kingdom